Mckesson Corporation
Irving, TX
- UEI
- S1RUKWWRYFL6
- CAGE
- 1MKG3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Biologics, Inc. · Cary, NC GVRYEDLFU6J3
- Medical & Vaccine Products, Inc. UNC7ZBMJQ994
- YJEDMKXMAHZ1
- CLKFHFWTKQP3
- Lebanon, OH X7ERZGHSPJL1
- E2YYZ8SMMVZ9
- Mckesson Corporation JTAPCFM4NSL4
- Irving, TX DEYNPZDTW249
- G2JQFE7NMHL1
- PHA9LWETENP2
- TK8FNJN6MSC3
- DYWBJZBFGHH3
- Henrico, VA DLTUFGNBD4R5
- JGBBJDD1ZR23
- K1C5RVS1NFF6
- Shepherdsville, KY M986PPZNJ8M8
- GF5KLLRTP2T4
- CBPRYWDGNR65
- Olive Branch, MS GY7SZLBCL9Y1
- Irving, TX GWZXFMRKFS27
- Mckesson Corporation JJNSGC9D1PG4
- PSS World Medical, Inc. NAF1E8NP62N4
- Ndchealth Corporation · Atlanta, GA XP67KC4FQWM7
- Mckesson Corporation · Memphis, TN VMJLFQE5U511
- HX8TZ4XWGSU5
25 subsidiaries listed here. See the rest on GovTribe.
-
- SAM.gov registration date
- Physical address
- 6555 State Hwy 161, Irving, TX 75039, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $23,605,335 |
| FY2026 | $11,153,778,255 |
| FY2025 | $11,870,613,720 |
| FY2024 | $9,003,867,346 |
| FY2023 | $9,529,383,766 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $10,876,316,728 | |
| 2 | Department of Justice | $208,748,281 | |
| 3 | Department of Health and Human Services | $74,466,522 | |
| 4 | Department of Homeland Security | $17,460,401 | |
| 5 | Peace Corps | $391,659 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Mriglobal | 75N91023D00010 | $66,199 | |
| Salado Isolation Mining Contractors, LLC | 89303322DEM000077 | -$4 | |
| Salado Isolation Mining Contractors, LLC | 89303322DEM000077 | $4 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Pfizer Inc. | New York, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Corporate Office | Conshohocken, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Avkare LLC | Pulaski, TN | 325412 Pharmaceutical Preparation Manufacturing |
| Prasco, LLC | Mason, OH | 325412 Pharmaceutical Preparation Manufacturing |
| Amerisourcebergen | Carrollton, TX | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
McKesson Corporation, headquartered in Irving, Texas, operates as a large business prime contractor supplying pharmaceutical distribution, controlled and non-controlled medications, specialty pharmaceuticals, medical consumables, and surgical medical supplies to federal agencies across 144 distinct customer organizations without small business set-asides. The company competes exclusively in full-and-open procurements as a large business and does not hold 8(a), HUBZone, SDVOSB, WOSB, or other disadvantaged-business certifications, though a subsidiary, Medical & Vaccine Products, Inc., is certified as a small disadvantaged business.
McKesson's federal footprint is massive and concentrated in pharmaceutical supply. The company has received 159,112 total federal prime awards since 1993, with combined potential value of $245.29 billion and $123.73 billion obligated. Across the past five years (2023–2027), the company averaged over 1,600 awards per year, though 2027 activity in the source is sparse. The portfolio is dominated by two primary NAICS categories: Drugs and Druggists' Sundries Merchant Wholesalers (99,867 awards) and Pharmaceutical Preparation Manufacturing (54,207 awards). The top PSC is Drugs and Biologicals (122,920 awards), followed by Replenishable Field Medical Sets, Kits, and Outfits (27,127 awards). Representative prime work includes a $15 million single-award blanket purchase agreement with the Office of Acquisition Management (awarded February 2026, through August 2028) for surgical medical supplies, distributed from McKesson's Doral, Florida facility; a $3.164 billion delivery order from Immigration and Customs Enforcement (September 2026) for pharmaceuticals for ICE Health Service Corps; and continuous flow of delivery orders from the Bureau of Prisons for controlled medications, medication-assisted treatment supplies, and regular pharmaceuticals across dozens of federal correctional facilities nationwide.
Customer concentration is extreme. The top customer by award count—Defense Logistics Agency Troop Support Medical—accounts for 40,730 awards and $4.46 billion in combined potential value, representing approximately 26% of the award count. By combined potential value, DLA Troop Support Medical remains the leading customer ($4.46 billion), followed by the Department of Health and Human Services Indian Health Service ($3.68 billion), and the Department of Justice Bureau of Prisons facilities, with Federal Correctional Complex Pollock ($214.7 million), Medical Center for Federal Prisoners Springfield ($95.8 million), and Federal Correctional Complex Coleman ($75.6 million) as top sub-customers. The top five customers by combined potential value account for roughly 3% of the $245.29 billion ceiling—a signal that McKesson's footprint is genuinely distributed across a broad customer base despite DLA dominance in transaction count.
Vehicle position reflects the company's role in large indefinite-delivery infrastructure. McKesson holds position on four major IDCs carrying tens of thousands of task orders: Indefinite Delivery Contract V797P1020 (48,229 task orders, $14.24 billion combined potential value), Indefinite Delivery Contract SPM20003D1666 (40,654 task orders, $4.46 billion), Indefinite Delivery Contract VA797P12D0001 (36,027 task orders, $46.6 billion), and Indefinite Delivery Contract 36W79720D0001 (10,434 task orders, $57.16 billion). Contract 36W79720D0001, which references the VA Pharmaceutical Prime Vendor program, is a federal workhorse vehicle; task orders from multiple Bureau of Prisons facilities explicitly cite this contract number for medication procurement. The source also identifies a $15 million single-award BPA with the Office of Acquisition Management for surgical medical supplies (performance through August 2028).
Recompete exposure in the next twenty-four months is modest: 176 awards with combined potential value of $91 million face completion and recompete. Activity trajectory through recent years shows year-over-year award counts of 2,267 (2023), 2,275 (2024), 1,964 (2025), and 1,125 (2026), indicating a decline from 2024 to 2026, though the 2027 data in the source is incomplete (only two awards recorded at time of snapshot). The recompete cliff is not pronounced relative to the overall portfolio size.
McKesson maintains 29 named subsidiaries, including Medical & Vaccine Products, Inc. (self-certified small disadvantaged business), McKesson Specialty Distribution LLC, PSS World Medical, Inc., and Edwards Medical Supply, Inc., among others. These subsidiaries carry distinct operational brands and capabilities but operate under the parent McKesson Corporation umbrella for federal contracting purposes. The company's sub-award footprint is negligible—only three sub-awards appear in the source, representing less than 0.01% of the total prime-award universe.
Quick answers
Is Mckesson Corporation registered in SAM.gov?
Yes. Mckesson Corporation's SAM.gov registration is active through September 18, 2027.
What is Mckesson Corporation's CAGE code?
Mckesson Corporation's CAGE code is 1MKG3, and its Unique Entity ID (UEI) is S1RUKWWRYFL6.
How much has Mckesson Corporation received in federal contracts?
Federal contracts obligated $11,870,613,720 to Mckesson Corporation in fiscal year 2025 and $41,581,248,423 in fiscal years 2023 through 2027.
How does Mckesson Corporation rank among federal contractors?
Mckesson Corporation ranked #1 in PSC 65, #1 in NAICS 325 and #2 at the Department of Justice in FY2025.
What is Mckesson Corporation's most recent federal award?
Mckesson Corporation's most recent federal contract award is Inmate medications-clean-FY27 (15B20927F00000006), from Federal Correctional Institution Mckean (BOP), on September 30, 2027.
On GovTribe
See Mckesson Corporation's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors